3 ” Dec 2021″SOURCE: AL JAZEERA AND NEWS AGENCIES
Iftiinka cagaaran ee maamulaha dawooyinka ayaa imanaya iyadoo shirkadda weyn ee dawooyinka ay leedahay natiijooyinka shaybaadhka ayaa muujinaya ‘dhaqdhaqaaq ka dhan ah isbeddellada muhiimka ah ee Omicron’.
Hal qiyaas oo sotrovimab ah ayaa la ogaaday inay hoos u dhigtay halista isbitaal dhigista iyo dhimashada 79 boqolkiiba dadka qaangaarka ah ee khatarta sare leh ee leh astaamaha COVID, sida uu qabo maamulaha dawooyinka UK []
Boqortooyada Midowday (UK) waxay oggolaatay adeegsiga daawada lagu daweynayo dadka khatarta sare ugu jira inay ku dhacaan calaamadaha COVID-19 ee daran, taasoo ay soo-saarayaashu sheegeen inay u muuqato mid waxtar u leh noocyada cusub ee Omicron.
Dawaynta antibody-ka, sotrovimab, “waxaa la ogaaday inay badbaado wax ku ool u tahay yaraynta halista cusbitaalka iyo dhimashada dadka qaba caabuqa COVID-19 fudud iyo dhexdhexaadka ah ee halista ugu jira inay qaadaan cuduro daran”, Daawooyinka iyo agabka daryeelka caafimaadka Wakaalada (MHRA) ayaa bayaan ay soo saartay ku sheegtay Khamiistii.
shirkad fadhigeedu yahay UK, iyo xarunteeda dhexe ee Mareykanka Vir Biotechnology.
Waa monoclonal antibody, nooc ka mid ah borotiinka oo ku dheggan borotiinka sare ee coronavirus, taas oo yaraynaysa awoodda uu u leeyahay inuu galo unugyada jidhka.
GSK ayaa sheegtay Khamiista in falanqaynta shaybaadhka ay muujisay dawadu inay wax ku ool u tahay fayrasyada loo sameeyay bio-engineered si ay u qaadaan tiro ka mid ah isbeddellada astaamaha ah ee kala duwanaanshaha Omicron, kaas oo si aad ah u isbeddelay marka loo eego noocyadii hore ee coronavirus.
Xogta saxda ah waxay muujisay in dawadu “ay sii hayso dhaqdhaqaaqa ka dhanka ah isbeddellada muhiimka ah ee kala duwanaanshaha cusub ee Omicron SARS-CoV-2,” shirkadda weyn ee dawooyinka ayaa bayaan ku sheegtay.
Tijaabooyinku way socdaan si loo xaqiijiyo natiijooyinka ka dhan ah dhammaan isbeddellada Omicron iyadoo la cusbooneysiinayo la filayo dhammaadka sanadka, ayay raacisay.
GSK waxay sheegtay in sotrovimab ay sidoo kale muujisay “hawlaha socda” ee ka dhan ah dhammaan noocyada kale ee la tijaabiyay ee welwelka iyo xiisaha ay aqoonsatay Ururka Caafimaadka Adduunka, oo ay ku jiraan nooca aadka loo kala qaado ee Delta kaas oo kiciyay kiisas badan oo qaybo badan oo Yurub ah, oo ah xuddunta hadda faafa, bilihii la soo dhaafay.
Daawaynta lagula tacaalayo dhibaatada caafimaad ee adduunka, oo ay ku dhinteen in ka badan shan milyan oo qof oo adduunka oo dhan ah, ayaa ilaa hadda inta badan diiradda lagu saaray tallaallada.
Saynis yahanka ugu sareeya Ururka Caafimaadka Adduunka (WHO) ayaa dadka ku booriyay inaysan ka argagixin soo ifbaxa kala duwanaanshaha Omicron coronavirus wuxuuna sheegay inay goor hore ahayd in la yiraahdo haddii tallaallada loo baahan yahay in dib loo shaqeeyo.
Iyadoo la hadlaysay Reuters Jimcihii, Soumya Swaminathan waxay sheegtay inaysan macquul ahayn in la saadaaliyo Omicron in uu noqon doono culeyska kale oo weyn.
Inkastoo Koonfur Afrika ay xoojisay ololaheeda tallaalka usbuuc ka dib markii la helay kala duwanaanshaha coronavirus Omicron, hadana wax badan weli lagma yaqaano Omicro壯陽藥 n, iyadoo qaybo ka mid ah Yurub ay la halgamayaan mowjad caabuqyo ah oo nooca Delta ee caanka ah.
